Werewolf Therapeutics Inc (HOWL)

NASDAQ

$0.37

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapies designed to boost the body's immune system for the treatment of cancer. The company is headquartered in Cambridge, Massachusetts.

Website: https://werewolftx.com

Sector:

Healthcare

Industry:

Biotechnology

68 analysts

Buy

Target: $7 (+1802.17%)

Market Cap

$16M

Beta (5Y)

2.05

Price Chart

Adjust inflation

Log

Valuation

Market Cap$16M

P/S10.21

P/B1.37

Profitability

Gross Profit (TTM)-$34M

EBITDA-$54M

EPS-$1.19

Financial Health

Debt-to-Equity262.9%

Growth & Risk

FCF 5Y CAGR+18.03%

Beta (5Y)2.05

Sharpe Ratio-0.90